Epigenetics in human disease and prospects for epigenetic therapy
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Epigenetic mechanisms, which involve DNA and histone modifications, result in the heritable silencing of genes without a change in their coding sequence. The study of human disease has focused on genetic mechanisms, but disruption of the balance of epigenetic networks can cause several major pathologies, including cancer, syndromes involving chromosomal instabilities, and mental retardation. The development of new diagnostic tools might reveal other diseases that are caused by epigenetic alterations. Great potential lies in the development of 'epigenetic therapies'--several inhibitors of enzymes controlling epigenetic modifications, specifically DNA methyltransferases and histone deacetylases, have shown promising anti-tumorigenic effects for some malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are three main types of epigenetic modifications: DNA methylation, histone modifications, and various RNA-mediated processes (39, 40).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [39]
In the citing paper
“and represents a prominent candidate to be a marker of ROS-induced mutagenesis and tumorigenesis41.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [41]
In the citing paper
“Activation and/or aberrant expression of a gene can contribute to the development of endometriosis, cancers, or other abnormalities.22”
From Altered genome-wide methylation in endometriosis (2014) · cites this paper as [22]
In the citing paper
“Many reports have demonstrated that epigenetic alterations play important roles in driving cancer initiation and progression [123, 124].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [123]
Citations
Cites
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143 · cited 1×
“On a more global level, the ICF (immunodeficiency, centromeric region instability and facial anomalies) syndrome is caused by mutations in the DNMT3b gene, which is an essential enzyme required for the establishment of DNA methylation pattern”
BackgroundThe fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648 · cited 1×
“Aberrant de novo methylation of CpG islands is a hallmark of human cancers and is found early during carcinogenesi”
BackgroundSelf-citationRett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440 · cited 1×
“Interactions between histone deacetylases (HDACs), histone methyltransferases and methylcytosine-binding protein”
BackgroundCancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344 · cited 1×
“Epigenetic silencing has been recognized as a third pathway satisfying Knudson's hypothesis that two hits are necessary for the silencing of tumour-suppressor gene”
BackgroundSelf-citationThe history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,327
Regulation of Heterochromatic Silencing and Histone H3 Lysine-9 Methylation by RNAi
Volpe, T. A., Kidner, C., Hall, I. M., Teng, G., Grewal, S. I. S., & Martienssen, R. A. (2002) · Science · doi:10.1126/science.1074973 · Cited by 2,055
Holliday, R., & Pugh, J. E. (1975) · Science · doi:10.1126/science.187.4173.226 · Cited by 1,972 · cited 5×
“Science 220, 1055–1057 (1983). insight review articles”
BackgroundInfluential
Cited by
Items 1,001–1,013 of 1,013
Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma
Hoffmann, F., Zarbl, R., Niebel, D., Sirokay, J. D., Fröhlich, A., Posch, C., Holderried, T. A. W., Brossart, P., Saavedra, G., Kuster, P., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00883-9 · Cited by 46
“Additionally, aberrant DNA methylation is an epigenetic hallmark of cancer and contributes to tumor progression by inactivating tumor suppressor genes [17].”
BackgroundDNA methylation signatures of autoimmune diseases in human B lymphocytes
Zouali, M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108622 · Cited by 52
Knoblich, N., Gundel, F., Brückmann, C., Becker-Sadzio, J., Frischholz, C., & Nieratschker, V. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.12.010 · Cited by 41
“DNA methylation is catalyzed by methyltransferases (DNMTs) (Egger et al., 2004; Jones and Takai, 2001), which transfer a methyl group from S-adenosyl-methionine to cytosine creating 5-methyl-cytosine (Sutherland and Costa, 2003).”
BackgroundAn integrative analysis of DNA methylation and RNA-Seq data for human heart, kidney and liver
Xie, L., Weichel, B., Ohm, J. E., & Zhang, K. (2011) · BMC Systems Biology · doi:10.1186/1752-0509-5-s3-s4 · Cited by 38
“Modern genetic studies have established that DNA methylation is required not only for embryonic development [8], but also plays a critical role in diseased status such as cancer [9].”
BackgroundEpigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity
Ruoß, M., Damm, G., Vosough, M., Ehret, L., Grom-Baumgarten, C., Petkov, M., Naddalin, S., Ladurner, R., Seehofer, D., Nussler, A., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020347 · Cited by 37
The Synergistic Effect of 5-Aza-2′-Deoxycytidine and 5-Fluorouracil on Drug-Resistant Tumors
Morita, S., Iida, S., Kato, K., Takagi, Y., Uetake, H., & Sugihara, K. (2006) · Oncology · doi:10.1159/000107110 · Cited by 29
Targeting protein-protein interaction between MLL1 and reciprocal proteins for leukemia therapy
Wang, Z.-H., Li, D.-D., Chen, W.-L., You, Q.-D., & Guo, X.-K. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.11.045 · Cited by 16
Salas-Pérez, F., Cuevas-Sierra, A., Cuervo, M., Goni, L., Milagro, F. I., Martínez, J. A., & Riezu-Boj, J. I. (2022) · Epigenetics · doi:10.1080/15592294.2021.1873629 · Cited by 16
“Epigenetics represents a cross-talk between the genome and the environment, and epigenetic changes are typically reversible and refer to chemical modifications to histones and DNA [7].”
BackgroundZebularine upregulates expression of CYP genes through inhibition of DNMT1 and PKR in HepG2 cells
Nakamura, K., Aizawa, K., Aung, K. H., Yamauchi, J., & Tanoue, A. (2017) · Scientific Reports · doi:10.1038/srep41093 · Cited by 16
Epigenetic memories and the evolution of infectious diseases
McLeod, D. V., Wild, G., & Úbeda, F. (2021) · Nature Communications · doi:10.1038/s41467-021-24580-0 · Cited by 12
Todorov, G., Mayilvahanan, K., Ashurov, D., & Cunha, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-45325-6 · Cited by 11
RetractedCoppola, S., Paparo, L., Bedogni, G., Nocerino, R., Costabile, D., Cuomo, M., Chiariotti, L., Carucci, L., Agangi, A., Napolitano, M., et al. (2025) · International Journal of Obesity · doi:10.1038/s41366-024-01626-z · Cited by 10
“Among the mechanisms by which MD in pregnancy may affect fetal programming and exert long-term protective effects on the offspring are epigenetic mechanisms [6, 36].”
Nemoto, T., Morita, Y., & Kakinuma, Y. (2023) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174423000363 · Cited by 4
“24 In contrast, noncoding RNAs that do not encode proteins, especially miRNAs, which are other factors that control the expression of genomic information, are beginning to attract increasing research attention.”
Background
Metadata
- Authors
- Egger, G., Liang, G., Aparicio, A., & Jones, P. A.
- Affiliations
- University of Southern California (US)
- Venue
- Nature
- Published
- 2004-05
- Volume
- 429
- Issue
- 6990
- Pages
- 457-463
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2004172747
- Cited by
- 3,232
- References
- 96
- Citations by year
- 2026: 32 · 2025: 76 · 2024: 100 · 2023: 132 · 2022: 124 · 2021: 175 · 2020: 140 · 2019: 173 · 2018: 185 · 2017: 192 · 2016: 180 · 2015: 208 · 2014: 159 · 2013: 175 · 2012: 153
- FWCI
- 10.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Max Kade Foundation
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Keywords
- epigenetics, epigenetic therapy, DNA methylation, histone modifications, gene silencing, hypomethylating agents, histone deacetylase inhibitors, cancer, chromosomal instability syndromes, intellectual disability
- MeSH terms
- Disease, Genetics, Medical, Humans, Genetic Therapy, DNA Methylation, Gene Silencing, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.